Is Stepan Company (SCL) overvalued? · P/E 22, rev $2.18B
Stepan Company (SCL) is a specialty chemicals company listed on US.
This page asks whether Stepan Company (SCL) looks expensive on cached numbers — not a short thesis.
Latest reported SCL revenue for 2024-12-31 was $2.18B. Net income was $50.4M. Revenue was down 6.3% from 2023-12-31 to 2024-12-31. SCL currently screens at market cap $1.29B and trailing P/E 22.3.
SCL currently screens at market cap $1.29B and trailing P/E 22.3. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next SCL 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the SCL stock page for the full model, not this heading.
Not investment advice.